Doxorubicin Recruiting Phase N/A Trials for Lymphoma, Hodgkins Treatment

IndicationsStatusPurposePhase
RecruitingTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01868451Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma